![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
"Treatment of Genotype 3 Cirrhotic patients with 12
weeks Sofosbuvir/Velpatasvir with or without ribavirin:
Real life experience from Italy"
|
|
|
Reported by Jules Levin
AASLD 2018 Nov 9-13 SF
Luisa Pasulo on behalf Italian Real life HCV cirrhotic G3 Study Group
(Navigatore Lombardy and Veneto, Piemonte, Tuscany, Sicily)
E-mail: lpasulo@asst-pg23.it
![1126181](../images%20/112618/112618-3/1126181.gif)
![1126182](../images%20/112618/112618-3/1126182.gif)
![1126183](../images%20/112618/112618-3/1126183.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|